Skip to main content
. 2014 Aug 14;10(5):2346–2350. doi: 10.3892/mmr.2014.2490

Figure 3.

Figure 3

Western blot analysis of phosphorylated (P)-p38 mitogen activated protein kinase (MAPK) and p38 MAPK protein expression from SKOV3/DDP cisplatin-resistant ovarian cancer cells following treatment with p38 MAPK inhibitor SB203580 for 72 h. GAPDH was used as an internal loading control.